MedPath

Kori-tofu proteins and blood glucose response

Completed
Conditions
blood glucose
glucose tolerance
10018424
Registration Number
NL-OMON48454
Lead Sponsor
Asahimatsu support B.V.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
24
Inclusion Criteria

Age 50-75yrs
BMI >25 kg/m2
Having veins suitable for blood sampling via a catheter
Having one or more of the following criteria:
o HbA1c> 6%
o fasting glucose >6.1mmol/L
o two-hour glucose levels >7.8 mmol/L on the 75-g oral glucose tolerance test.

Exclusion Criteria

* History of gastro-intestinal surgery or having (serious) gastro-intestinal
complaints
* History of liver dysfunction (cirrhosis, hepatitis) or liver surgery
* Kidney dysfunction (self-reported)
* Use of medication/supplements that may influence the study results, such as
med-icines known to interfere with glucose homeostasis (judged by our study
doctor)
* Anaemia (Hb values <7.5 for women and <8.5 for men)
* Reported slimming, medically prescribed or other extreme diets
* Reported weight loss or weight gain of > 5 kg in the month prior to pre-study
screening
* Not willing to give up blood donation during the study
* Current smokers
* Alcohol intake *4 glasses of alcoholic beverages per day
* Abuse of drugs
* Food allergies for products that we use in the study
* Participation in another clinical trial at the same time
* Being an employee of the Food, Health & Consumer Research group of
Wa-geningen Food & Biobased Research.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The primary study parameter will be the change in blood glucose levels after<br /><br>consumption of the test meal</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>The secondary study parameter will be the change in blood insulin levels after<br /><br>consumption of the test meal</p><br>
© Copyright 2025. All Rights Reserved by MedPath